New York State Common Retirement Fund Reduces Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

New York State Common Retirement Fund lowered its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,439 shares of the biotechnology company’s stock after selling 2,500 shares during the quarter. New York State Common Retirement Fund’s holdings in Axon Enterprise were worth $22,251,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise during the 4th quarter valued at approximately $40,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise during the fourth quarter valued at $45,000. Prestige Wealth Management Group LLC grew its holdings in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares during the last quarter. Stonebridge Financial Group LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at $53,000. Finally, GPS Wealth Strategies Group LLC raised its stake in Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after acquiring an additional 40 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Joshua Isner sold 1,291 shares of the stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the transaction, the president now directly owns 181,892 shares in the company, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is owned by company insiders.

Axon Enterprise Trading Down 5.3 %

AXON stock opened at $513.22 on Friday. Axon Enterprise, Inc. has a 52-week low of $265.32 and a 52-week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $39.13 billion, a P/E ratio of 132.62, a PEG ratio of 5.95 and a beta of 1.05. The company’s 50-day simple moving average is $619.94 and its 200-day simple moving average is $517.11.

Wall Street Analyst Weigh In

Several analysts have weighed in on AXON shares. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. JMP Securities upped their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a report on Tuesday, February 4th. Finally, Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $561.31.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.